GRANT PICKERING - 01 Mar 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
01 Mar 2023
Net transactions value
-$128,578
Form type
4
Filing time
03 Mar 2023, 16:09:07 UTC
Previous filing
04 Jan 2023
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +53,875 +14% $0.000000 428,351 01 Mar 2023 Direct F1
transaction PCVX Common Stock Tax liability $128,578 -3,099 -0.72% $41.49 425,252 02 Mar 2023 Direct F2
holding PCVX Common Stock 157,830 01 Mar 2023 By Children's Trust F3
holding PCVX Common Stock 157,830 01 Mar 2023 By Children's Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +323,250 $0.000000 323,250 01 Mar 2023 Common Stock 323,250 $41.67 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2023 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
F2 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F3 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F4 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F5 1/48 of shares subject to the option vest on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.